Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
- Study Title
- A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
- Teva Identifier
- TVP-1012/500 (ADAGIO)
- ClinicalTrials.gov Identifier
- NCT00256204
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: Rasagiline Mesylate | Other: Placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 30 Years to 80 Years
- Trial Duration
- 11/01/2005 - 06/01/2009
- Phase
- Phase 3
